GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23692
Submission : 2010-04-06
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23692
Submission : 2010-04-06
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : TOBRAMYCIN AND DEXAMETHASONE
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 64134
Country : US
Patented : No
Drug : TOBRAMYCIN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 64052
Country : US
Patented : No
Drug : AKTOB
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 64096
Country : US
Patented : No
Drug : TOBRADEX ST
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 50818
Country : US
Patented : Yes
Drug : NEVANAC
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 21862
Country : US
Patented : Yes
Drug : ALOMIDE
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 20191
Country : US
Patented : No
Drug : TOBREX
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 50541
Country : US
Patented : No
Drug : GENTAMICIN SULFATE
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 62196
Country : US
Patented : No
Drug : TOBRADEX
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Application Number : 50592
Country : US
Patented : No
Drug : CIPRODEX
Dosage Form : SUSPENSION/DROPS; OTIC
Application Number : 21537
Country : US
Patented : Yes
EXCIPIENTS BY APPLICATIONS
Application : Solubilizers
Excipient Details : Tyloxapol excipient is used as an solubilizing agent in the ophthalmic products.
MARKET PLACE
Reply
07 May 2022
Reply
16 Jan 2021
LOOKING FOR A SUPPLIER?